245 related articles for article (PubMed ID: 18030487)
21. CD4+ T-cell type 1 and type 2 cytokines in the HSV-1 infected cornea.
Heiligenhaus A; Bauer D; Zheng M; Mrzyk S; Steuhl KP
Graefes Arch Clin Exp Ophthalmol; 1999 May; 237(5):399-406. PubMed ID: 10333107
[TBL] [Abstract][Full Text] [Related]
22. Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFN-gamma knockout mice.
Bouley DM; Kanangat S; Wire W; Rouse BT
J Immunol; 1995 Oct; 155(8):3964-71. PubMed ID: 7561104
[TBL] [Abstract][Full Text] [Related]
23. Herpesvirus Entry Mediator Binding Partners Mediate Immunopathogenesis of Ocular Herpes Simplex Virus 1 Infection.
Park SJ; Riccio RE; Kopp SJ; Ifergan I; Miller SD; Longnecker R
mBio; 2020 May; 11(3):. PubMed ID: 32398314
[TBL] [Abstract][Full Text] [Related]
24. Cytokine production in a murine model of recurrent herpetic stromal keratitis.
Stumpf TH; Shimeld C; Easty DL; Hill TJ
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):372-8. PubMed ID: 11157869
[TBL] [Abstract][Full Text] [Related]
25. Application of FGF-2 to modulate herpetic stromal keratitis.
Kim B; Lee S; Kaistha SD; Rouse BT
Curr Eye Res; 2006 Dec; 31(12):1021-8. PubMed ID: 17169840
[TBL] [Abstract][Full Text] [Related]
26. Activated inflammatory infiltrate in HSV-1-infected corneas without herpes stromal keratitis.
Divito SJ; Hendricks RL
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1488-95. PubMed ID: 18385067
[TBL] [Abstract][Full Text] [Related]
27. Development of lacrimal gland inflammation in the mouse model of herpes stromal keratitis.
Rao P; McKown RL; Laurie GW; Suvas S
Exp Eye Res; 2019 Jul; 184():101-106. PubMed ID: 31009613
[TBL] [Abstract][Full Text] [Related]
28. Interferon gamma is not required for recurrent herpetic stromal keratitis.
Keadle TL; Alexander DE; Leib DA; Stuart PM
Virology; 2008 Oct; 380(1):46-51. PubMed ID: 18755490
[TBL] [Abstract][Full Text] [Related]
29. Prevention of herpes simplex virus induced stromal keratitis by a glycoprotein B-specific monoclonal antibody.
Krawczyk A; Dirks M; Kasper M; Buch A; Dittmer U; Giebel B; Wildschütz L; Busch M; Goergens A; Schneweis KE; Eis-Hübinger AM; Sodeik B; Heiligenhaus A; Roggendorf M; Bauer D
PLoS One; 2015; 10(1):e0116800. PubMed ID: 25587898
[TBL] [Abstract][Full Text] [Related]
30. Herpetic stromal keratitis: an immunopathologic disease mediated by CD4+ T lymphocytes.
Doymaz MZ; Rouse BT
Invest Ophthalmol Vis Sci; 1992 Jun; 33(7):2165-73. PubMed ID: 1351475
[TBL] [Abstract][Full Text] [Related]
31. Incidence and severity of herpetic stromal keratitis: impaired by the depletion of lymph node macrophages.
Bauer D; Mrzyk S; Van Rooijen N; Steuhl KP; Heiligenhaus A
Exp Eye Res; 2001 Mar; 72(3):261-9. PubMed ID: 11180975
[TBL] [Abstract][Full Text] [Related]
32. Influence of antisense oligonucleotides targeting tumor necrosis factor-alpha on experimental herpetic-induced chorioretinitis of mouse eye.
Mei H; Xing Y; Yang J; Wang A; Xu Y; Heiligenhaus A
Pathobiology; 2009; 76(1):45-50. PubMed ID: 19188750
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of Effect of Topical Tacrolimus Treatment on Herpetic Stromal Keratitis in a Rat Model.
Eriş E; Yüksel N; Pirhan D; Karadenizli A; Aslan M; Gacar G; Erman G; Subaş C; Uzuner H; Yldz DK; Karaöz E
Eye Contact Lens; 2016 May; 42(3):163-70. PubMed ID: 25996419
[TBL] [Abstract][Full Text] [Related]
34. Tetrandrine potently inhibits herpes simplex virus type-1-induced keratitis in BALB/c mice.
Hu S; Dutt J; Zhao T; Foster CS
Ocul Immunol Inflamm; 1997 Sep; 5(3):173-80. PubMed ID: 9326762
[TBL] [Abstract][Full Text] [Related]
35. HSV-1 antigens and DNA in the corneal explant buttons of patients with non-herpetic or clinically atypical herpetic stromal keratitis.
Garweg JG; Russ CE; Schellhorn M; Böhnke M; Halberstadt M
Graefes Arch Clin Exp Ophthalmol; 2003 Sep; 241(9):734-9. PubMed ID: 12827375
[TBL] [Abstract][Full Text] [Related]
36. Improvement of HSV-1 necrotizing keratitis with amniotic membrane transplantation.
Heiligenhaus A; Bauer D; Meller D; Steuhl KP; Tseng SC
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):1969-74. PubMed ID: 11481259
[TBL] [Abstract][Full Text] [Related]
37. Effect of herpes simplex virus-1 gD or gD-IL-2 DNA vaccine on herpetic keratitis.
Inoue T; Inoue Y; Hayashi K; Shimomura Y; Fujisawa Y; Aono A; Tano Y
Cornea; 2002 Oct; 21(7 Suppl):S79-85. PubMed ID: 12484704
[TBL] [Abstract][Full Text] [Related]
38. [Suppression effects of interleukin-10 on mouse herpetic stromal keratitis].
Xia LK; Gao DW; Pu W; Zhang JS
Zhonghua Yan Ke Za Zhi; 2003 Oct; 39(10):592-6. PubMed ID: 14766072
[TBL] [Abstract][Full Text] [Related]
39. The role of a glycoprotein K (gK) CD8+ T-cell epitope of herpes simplex virus on virus replication and pathogenicity.
Mott KR; Chentoufi AA; Carpenter D; BenMohamed L; Wechsler SL; Ghiasi H
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2903-12. PubMed ID: 19168902
[TBL] [Abstract][Full Text] [Related]
40. Lornoxicam suppresses recurrent herpetic stromal keratitis through down-regulation of nuclear factor-kappaB: an experimental study in mice.
Yin J; Huang Z; Xia Y; Ma F; Zhang LJ; Ma HH; Li Wang L
Mol Vis; 2009 Jun; 15():1252-9. PubMed ID: 19547717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
